P

PTC Therapeutics
D

PTCT

43.830
USD
0.91
(2.12%)
Market Open
Volume
8,449
EPS
-5
Div Yield
-
P/E
-7
Market Cap
3,380,395,018
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    C
    CRNX
    -4.900
    (-8.21%)
    54.790 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    G
    GLPG
    -1.130
    (-4.05%)
    26.780 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    S
    SLDB
    -0.45000
    (-8.46%)
    4.87000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    More
News

Title: PTC Therapeutics

Sector: Healthcare
Industry: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.